Universal Biosensors, Inc. (ASX: UBI) has been advised by LifeScan, Inc. that LifeScan has been granted
regulatory clearance to sell the OneTouch Verio® product as sold in Australia by the United States Food
and Drug Administration.
Chairman and Interim CEO, Andrew Denver noted “We are pleased that the FDA has approved the Verio
system. It is another step in the commercialisation of the UBI developed product. However it must be noted
that LifeScan have not disclosed their plans for a US launch, a decision which is solely within their control.”
Read the full report
All News